Blog: RALLYBIO CORP : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 2.02 Results of Operations and Financial Condition.

On March 6, 2023, Rallybio Corporation issued a press release announcing its
financial results for the quarter and year ended December 31, 2022. A copy of
the press release is furnished as Exhibit 99.1 to this Current Report on Form
8-K.

The information contained in Item 2.02 of this Current Report on Form 8-K
(including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the Exchange Act) or
otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933 or the
Exchange Act, except as expressly set forth by specific reference in such a
filing.

Item 7.01. Regulation FD Disclosure.

On March 6, 2023, Rallybio Corporation issued a press release announcing that
clinical proof-of-concept has been achieved in a Phase 1b study for RLYB212, an
anti-HPA-1a monoclonal antibody for the prevention of Fetal and Neonatal
Alloimmune Thrombocytopenia. Results show that one week after a single
subcutaneous dose, RLYB212 was able to rapidly and completely eliminate
transfused, HPA-1a positive platelets in HPA-1a negative subjects. A copy of the
press release is furnished as Exhibit 99.2 to this Current Report on Form 8-K
and is incorporated herein by reference.

The information contained in this Item 7.01 of this Current Report on Form 8-K
(including Exhibit 99.2) shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the Exchange Act) or
otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933 or the
Exchange Act, except as expressly set forth by specific reference in such a
filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits
Exhibit No.    Description
99.1             Press release issued by the Company on March 6, 2023 regarding financial
               results for the fiscal quarter and year ended December 31, 2022
99.2             Press release issued by the Company on March 6, 2023
104            Cover Page Interactive Data File (embedded within the Inline XBRL document)

——————————————————————————–

——————————————————————————–

© Edgar Online, source Glimpses